Skip to main content

Substance Misuse

  • Chapter

Part of the Forensic Science and Medicine book series (FSM)

Abstract

The number of individuals passing through the criminal justice system with substance misuse problems is increasing, and doctors should be aware of current drug trends in their area.

Keywords

  • Anabolic Steroid
  • Withdrawal Syndrome
  • Alcohol Withdrawal
  • Substance Misuse
  • Blood Alcohol

These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

This is a preview of subscription content, access via your institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • DOI: 10.1385/1-59259-913-3:285
  • Chapter length: 42 pages
  • Instant PDF download
  • Readable on all devices
  • Own it forever
  • Exclusive offer for individuals only
  • Tax calculation will be finalised during checkout
eBook
USD   109.00
Price excludes VAT (USA)
  • ISBN: 978-1-59259-913-4
  • Instant PDF download
  • Readable on all devices
  • Own it forever
  • Exclusive offer for individuals only
  • Tax calculation will be finalised during checkout

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. National Institute of Justice. 2000 Arrestee Drug Abuse Monitoring: Annual Report. U.S. Department of Justice, Office of Justice Programs, Washington D.C., 2000.

    Google Scholar 

  2. Bennett, T. and Holloway K. Drug use and offending: summary results of the first two years of the NEW-ADAM programme. Findings 179. Home Office Research, Development and Statistics Directorate. London: Home Office. Detailed report available online—Holloway, K. and Bennett, T. The results of the first two years of the NEW-ADAM programme. Home Office Online Report 19/04. Research, Development and Statistics Directorate. London: Home Office, 2004.

    Google Scholar 

  3. Association of Police Surgeons and Royal College of Psychiatrists. Substance Misuse Detainees in Police Custody. Guidelines for Clinical Management, 2nd Ed. Report of a Medical Working Group. Council Report CR81. London: Royal College of Psychiatrists, 2000.

    Google Scholar 

  4. Drug Enforcement Administration. Illegal Drug Price and Purity Report. Drug Intelligence Report. US Department of Justice. Drug Enforcement Administration, 2003

    Google Scholar 

  5. Corkery, J. M. Drug Seizure and Offender Statistics, United Kingdom 2002. Home Office, London, 2002.

    Google Scholar 

  6. Nicholson, F. Infectious diseases and an at risk exposure. In: Stark M.M., Rogers D.J., Norfolk G.A. eds., Good Practice Guidelines for Forensic Medical Examiners-Metropolitan Police. GPG Editors, Oxford, 2004.

    Google Scholar 

  7. Norfolk, G. A., and Gray S. F. Intravenous drug users and broken needles—a hidden risk? Addiction. 98:1163–1166, 2003.

    PubMed  Google Scholar 

  8. Wallace, P., Cutler, S., Haines, A. Randomised controlled trial of general practitioner intervention in patients with excessive alcohol consumption. Br. Med. J. 297:663–668, 1988.

    CAS  Google Scholar 

  9. Porchaska, J. O., and Clemente. C. C. The Transtheoretical Approach: Crossing Traditional Boundaries of therapy, Dow-Jones-Irwin, Homewood, IL, 1984.

    Google Scholar 

  10. Edmunds, M., May, T., Hearnden, I., Hough, M. Arrest Referral: Emerging Lessons from Research. Home Office Drugs Prevention Initiative Paper 23. Home Office, London, 1998.

    Google Scholar 

  11. Department of Health. The Scottish Office Department of Health. Welsh Office. Department of Health and Social Services, Northern Ireland. Drug Misuse and Dependence—Guidelines on Clinical Management. Her Majesty’s Stationery Office, London, 1999.

    Google Scholar 

  12. Tennant, F. and Shannon, J. Cocaine abuse in methadone maintenance patients is associated with low serum methadone concentrations. J. Addict. Dis. 14:67–74, 1995.

    PubMed  CAS  Google Scholar 

  13. Gossop, M., Marsden, J., Stewart, D., Kidd, T. The National Treatment Outcome Research Study (NTORS): 4-5 year follow-up results. Addiction. 98:291–303, 2003.

    PubMed  Google Scholar 

  14. Karch, S. B. Medical consequences of opiate abuse. In: Karch, S. B., ed., The Pathology of Drug Abuse. CRC Press, Boca Raton, 2002, pp. 392–400.

    Google Scholar 

  15. Nutt, D. J. Addiction: brain mechanisms and their treatment implications. Lancet. 347:31–36, 1996.

    PubMed  CAS  Google Scholar 

  16. Ling, W. and Wesson, D. R. Drugs of abuse: opiates, in addiction medicine (Special Edition). West. J. Med. 152: 565–572, 1990.

    PubMed  CAS  Google Scholar 

  17. Phillips, G. T., Gossop, M., Bradley, B. The influence of psychological factors on opiate withdrawal syndrome. Brit. J. Psychiatry. 149:235–238, 1986.

    CAS  Google Scholar 

  18. Ruben, S. M., McLean, P. C., Melville, J. Cyclizine abuse among a group of opiate dependents receiving methadone. Br. J. Addict. 84:929–934, 1989.

    PubMed  CAS  Google Scholar 

  19. De Wet, C.J., Reed, L.J., Glasper, A., Moran, P. Bearn, J., Gossop, M. Benzodiazepine co-dependence exacerbates the opiate withdrawal syndrome. SSA Symposium Abstracts. Addict. Biol. 9:100, 2004.

    Google Scholar 

  20. Evans, J. V. Dihydrocodeine detox regime. HMP Manchester, personal communication, 1998.

    Google Scholar 

  21. Washton, A. M., Resnick, R. B., Geyer, G. Opiate withdrawal using lofexidine, a clonidine analogue with few side effects. J. Clin. Psychiatry. 44, 335–337, 1983.

    PubMed  CAS  Google Scholar 

  22. Ford, C., Morton, S., Lintzeris, N., Bury, J., Gerada C. Guidance for the Use of Buprenorphine for the Treatment of Opioid Dependence in Primary Care. Royal College of General Practitioners, London, 2003.

    Google Scholar 

  23. Stark, M. M. Substance misusers (drugs and alcohol) in custody. In: Stark M.M., Rogers D.J., and Norfolk G.A., eds., Good Practice Guidelines for Forensic Medical Examiners—Metropolitan Police. GPG Editors, Oxford, 2004.

    Google Scholar 

  24. Roth, B., Benowitz, N., Olson, K. Emergency management of drug-abuse-related disorders. In: Karch, S. B., ed., Drug Abuse Handbook, CRC Press, Boca Raton, FL, pp. 567–639, 1998.

    Google Scholar 

  25. Ghodse, H. Drugs of abuse and dependence. In: Ghodse, H. ed., Drugs and Addictive Behaviour—A Guide to Treatment. Cambridge University Press, Cambridge, 2002, p. 105.

    Google Scholar 

  26. Yealy, D. M., Paris, P. M., Kaplan, R. M., Heller, M. B., Marini, S. E. The safety of prehospital naloxone administration by paramedics. Ann. Emerg. Med. 19:902–905, 1990.

    PubMed  CAS  Google Scholar 

  27. Jones, A. L. Initial management of poisoned patients in the out-of-hospital environment. Pre-Hospital Immediate Care. 2:141–149, 1998.

    Google Scholar 

  28. Merigian, K. S. Cocaine-induced ventricular arrhythmias and rapid atrial fibrillation temporarily related to naloxone administration. Am. J. Emerg. Med. 11:96–97, 1993.

    PubMed  CAS  Google Scholar 

  29. Ashton, H. Guidelines for the rational use of benzodiazepines. When and what to use. Drugs. 48:25–40, 1994.

    PubMed  CAS  Google Scholar 

  30. Cowen, P. J. and Nutt, D. J. Abstinence symptoms after withdrawal of tranquillising drugs. Is there a common neurochemical mechanism? Lancet. 2:360–362, 1982.

    PubMed  CAS  Google Scholar 

  31. Bezchlibnyk-Butler, K. Z., Jeffries, J. J. Clinical Handbook of Psychotropic Drugs. Hogrefe and Huber, Toronto, 1996.

    Google Scholar 

  32. Vgontzas, A. N., Kales, A., Bixler, E. O. Benzodiazepine side effects: role of pharmacokinetics and pharmacodynamics. Pharmacology. 51:205–223, 1995.

    PubMed  CAS  Google Scholar 

  33. Editorial. Tranquillisers causing aggression. Br. Med. J. 1:113–114, 1975.

    Google Scholar 

  34. Gordon, E. B. Tranquillisers causing aggression. Br. Med. J. 2:36–37, 1975.

    PubMed  CAS  Google Scholar 

  35. Zevin, S., and Benowitz, N. L. Drug-related syndromes. In: Karch, S. B., ed., Drug Abuse Handbook. CRC Press, Boca Raton, FL, pp. 559–560, 1998.

    Google Scholar 

  36. Ashton, H. Benzodiazepine withdrawal: an unfinished story. Br. Med. J. 288:1135–1140, 1984.

    CAS  Google Scholar 

  37. Petursson, H. The benzodiazepine withdrawal syndrome. Addiction. 89:1455–1459, 1994.

    PubMed  CAS  Google Scholar 

  38. Roald, O. K., and Dahl, V. Flunitrazepam intoxication in a child successfully treated with the benzodiazepine antagonist flumazenil. Crit Care Med. 17:1355–1356, 1989.

    PubMed  CAS  Google Scholar 

  39. Hojer, J., Baehrendtz, S., Matell, G., Gustafsson, L. L. Diagnostic utility of flumazenil in coma with suspected poisoning: a double blind randomised controlled study. Br. Med. J. 301:1308–1311, 1990.

    CAS  Google Scholar 

  40. Katz, Y., Boulos, M., Singer, P., Rosenberg, B. Cardiac arrest associated with Flumazenil. Br. Med. J. 304,:1415, 1992.

    CAS  Google Scholar 

  41. Ives, R. Drug Notes: 6 Solvents. Drugscope, London, 2002.

    Google Scholar 

  42. Al-Alousi, L. M. Pathology of volatile substance abuse: a case report and a literature review. Med Sci Law. 29:189–208, 1989.

    PubMed  CAS  Google Scholar 

  43. Ron, M. A. Volatile substance abuse: a review of possible long-term neurological, intellectual and psychiatric sequelae. Br. J. Psychiatry. 148:235–246, 1986.

    PubMed  CAS  Google Scholar 

  44. Shepherd, R. T. Mechanism of sudden death associated with volatile substance abuse. Hum Toxicol. 8:287–292, 1989.

    PubMed  CAS  Google Scholar 

  45. Taylor, G. J. and Harris, W. S. Cardiac toxicity of aerosol propellants. JAMA. 214:81–85, 1970.

    PubMed  CAS  Google Scholar 

  46. Merry, J. and Zachariadis, N. Addiction to glue sniffing. Br. Med. J. 2:1448, 1962.

    PubMed  CAS  Google Scholar 

  47. Leikin, J. B., Krantz, A. J., Zell-Kanter, M., Barkin, R. L., Hryhorczuk, D. O. Clinical features and management of intoxication due to hallucinogenic drugs. Med. Toxicol. Adverse Drug Exp. 4:324–350, 1989.

    PubMed  CAS  Google Scholar 

  48. Hollister, L. E. and Hartman, A. M. Mescaline, lysergic acid diethylamide and psilocybin: comparison of clinical syndromes, effects on color perception and biochemical measures. Comp. Psychiatry. 3:235–241, 1962.

    CAS  Google Scholar 

  49. Abraham, H. D. and Aldridge, A. M. Adverse consequences of lysergic acid diethylamide. Addiction. 88:1327–1334, 1993.

    PubMed  CAS  Google Scholar 

  50. Schwartz, R. H. LSD. Its rise, fall and renewed popularity among high school students. Pediatric Clin. North Am. 42:403–413, 1995.

    CAS  Google Scholar 

  51. McCarron, M. M., Schulze, B. W., Thompson, G. A., Conder, M.C., Goetz, W. A. Acute phencyclidine intoxication:clinical patterns, complications and treatment. Ann. Emerg. Med. 10:290–297, 1981.

    PubMed  CAS  Google Scholar 

  52. Brust, J. C. M. Other agents. Phencyclidine, marijuana, hallucinogens, inhalants and anticholinergics. Neurol. Clin. 11, 555–561, 1993.

    PubMed  CAS  Google Scholar 

  53. Aniline, O. and Pitts Jr, F. N. Phencyclidine (PCP): a review and perspectives. Crit. Rev. Toxicol. 10:145–177, 1982.

    PubMed  CAS  Google Scholar 

  54. Steele, T. D., McCann, U. D., Ricaurte, G. A. 3,4-Methylenedioxymethamphetamine (MDMA, “ecstasy”): pharmacology and toxicology in animals and humans. Addiction. 89:539–551, 1994.

    PubMed  CAS  Google Scholar 

  55. Maxwell, D. L., Polkey, M. I., Henry, J. A. Hyponatraemia and catatonic stupor after taking “ecstasy.” Br. Med. J. 307:1399, 1993.

    CAS  Google Scholar 

  56. Kessel, B. Hyponatraemia after ingestion of “ecstasy.” Br. Med. J. 308:414, 1994.

    CAS  Google Scholar 

  57. Henry, J. A., Fallon, J. K., Kicman, A. T., Hutt, A. J., Cowan, D. A., Forsling, M. Low-dose MDMA (“ecstasy”) induces vasopressin secretion. Lancet. 351:1784, 1998.

    PubMed  CAS  Google Scholar 

  58. Redfearn, P. J., Agrawal, N., Mair, L. H. An association between the regular use of 3,4, methylenedioxy-methamphetamine (ecstasy) and excessive wear of the teeth. Addiction. 93:745–748, 1998.

    PubMed  CAS  Google Scholar 

  59. Shearman, J. D., Chapman, R. W. G., Satsangi, J., Ryley, N. G. Misuse of ecstasy. Br. Med. J. 305:309, 1992.

    CAS  Google Scholar 

  60. Creighton, F. J., Black, D. L., Hyde, C. E. “Ecstasy” psychosis and flashbacks. Br. J. Psychiatry. 159:713–715, 1991.

    PubMed  CAS  Google Scholar 

  61. Levine, A. J., Drew, S., Rees, G. M. “Ecstasy” induced pneumomediastinum. J. Royal Soc. Med. 86:232–233, 1993.

    CAS  Google Scholar 

  62. Bryden, A. A., Rothwell, P. J. N., O’Reilly, P. H. Urinary retention with misuse of “ecstasy”. Br. Med. J. 310:504, 1995.

    CAS  Google Scholar 

  63. Chadwick, I. S., Curry, P. D., Linsley, A., Freemont, A. J., Doran, B. Ecstasy, 3-4 methylenedioxymethamphetamine (MDMA), a fatality associated with coagulopathy and hyperthermia. J. Royal Soc. Med. 84:371, 1991.

    CAS  Google Scholar 

  64. Brown, C., and Osterloh, J. Multiple severe complications from recreational ingestion of MDMA (“ecstasy”). JAMA. 258:780–781, 1987.

    PubMed  CAS  Google Scholar 

  65. Dowling, G. P., McDonough, E. T., Bost, R. O. “Eve” and “ecstasy.” A report of five deaths associated with the use of MDEA and MDMA. JAMA. 257:1615–1617, 1987.

    PubMed  CAS  Google Scholar 

  66. Campkin, N. T. A. and Davies, U. M. Another death from Ecstasy. J. Royal Soc. Med. 85:61, 1992.

    CAS  Google Scholar 

  67. McGuire, P. and Fahy, T. Chronic paranoid psychosis after misuse of MDMA (ecstasy). Br. Med. J. 302:697, 1991.

    CAS  Google Scholar 

  68. Sternbach, H. The serotonin syndrome. Am. J. Psychiatry. 148:705–713, 1991.

    PubMed  CAS  Google Scholar 

  69. Mueller, P. D. and Korey, W. S. Death by “ecstasy”: the serotonin syndrome? Ann. Emerg. Med. 32:377–380, 1991.

    Google Scholar 

  70. McCann, U. D., Szabo, Z., Scheffel, U., Dannals, R. F., Ricaurte, G. A. Positron emission tomographic evidence of toxic effect of MDMA (“ecstasy”) on brain serotonin neurons in human beings. Lancet. 352:1433–1437, 1998.

    PubMed  CAS  Google Scholar 

  71. James, R. A. and Dinan, A. Hyperpyrexia associated with fatal paramethoxyamphetamine (PMA) abuse. Med Sci Law. 38:83–85, 1998.

    PubMed  CAS  Google Scholar 

  72. Resnick, R. B., Kestenbaum, R. S., Schwartz, L. K. Acute systemic effects of cocaine in man—a controlled study by intranasal and intravenous routes. Science. 195:696–698, 1977.

    PubMed  CAS  Google Scholar 

  73. Karch, S. B. Cocaine. In: Karch, S. B., ed., The Pathology of Drug Abuse. CRC Press, Boca Raton, FL, 2002, pp. 91–120.

    Google Scholar 

  74. Griffiths, P., Gossop, M., Wickenden, S., Dunworth, J., Harris, K., Lloyd, C. A transcultural pattern of drug use: qat (khat) in the UK. Br. J. Psychiatry. 170:281–284, 1997.

    PubMed  CAS  Google Scholar 

  75. Ahmed, A. G., and Salib, E. The Khat users: a study of khat chewing in Liverpool’s Somali men. Med Sci Law. 38:165–169, 1998.

    PubMed  CAS  Google Scholar 

  76. Joyce, H. Khat. J. Forensic Psychiatry. 5:228–231, 1994.

    Google Scholar 

  77. Luqman, W., and Danowski, T. S. The use of khat (Catha edulis) in Yemen. Social and medical observations. Ann. Intern. Med. 85, 246–249, 1976.

    PubMed  CAS  Google Scholar 

  78. Yousef, G., Huq, Z., Lambert, T. Khat chewing as a cause of psychosis. Br. J. Hosp. Med. 54:322–326, 1995.

    PubMed  CAS  Google Scholar 

  79. Pantelis, C., Hindler, C. G., Taylor, J. C. Use and abuse of khat (Catha edulis): a review of the distribution, pharmacology, side effects, and a description of psychosis attributed to khat chewing. Psychol Med. 19:657–658, 1989.

    PubMed  CAS  Google Scholar 

  80. Condon, J., and Smith, N. Prevalence of drug use: key findings from the 2002/2003 British Crime Survey. Home Office Research, Development and Statistics Directorate. London, 2003.

    Google Scholar 

  81. Cohen, J., and Hayes, G. Drug Notes: 3 Cannabis. Drugscope, London, 2002.

    Google Scholar 

  82. Wylie, A. S., Scott, R. T. A., Burnett, S. J. Psychosis due to “skunk.” Br. Med. J. 311:125, 1995.

    CAS  Google Scholar 

  83. British Medical Association. Therapeutic Uses of Cannabis. Harwood Academic Publishers, Amsterdam, 1997, pp. 19–20.

    Google Scholar 

  84. Stephens, R. S., Roffman, R. A., Simpson, E. E. Adult marijuana users seeking treatment. J. Consult. Clin. Psychol. 61:1100–1104, 1993.

    PubMed  CAS  Google Scholar 

  85. Bhasin, S., Storer, T. W., Berman, N., et al. The effects of superphysiologic doses of testosterone on muscle size and strength in normal men. N. Engl. J. Med. 335:1–7, 1996.

    PubMed  CAS  Google Scholar 

  86. Kennedy, M. Athletes, drugs and adverse reactions. Adverse Drug Reaction Bull. 143, 536–539, 1990.

    Google Scholar 

  87. ISDD. Drug Notes 9: Anabolic Steroids. ISDD, London.

    Google Scholar 

  88. Haupt, H. A. and Rovere, G. D. Anabolic steroids: a review of the literature. Am. J. Sports Med. 12:469–484, 1984.

    PubMed  CAS  Google Scholar 

  89. Stanley, A. and Ward, M. Anabolic steroids—the drugs that give and take away manhood. A case with an unusual physical sign. Med. Sci. Law. 34, 82–83, 1994.

    PubMed  CAS  Google Scholar 

  90. Lloyd, F. H. Powell, P., Murdoch, A. P. Anabolic steroid abuse by body builders and male subfertility. Br. Med. J. 313:100–101, 1996.

    CAS  Google Scholar 

  91. Creagh, T. M., Rubin, A., Evans, D. J. Hepatic tumours induced by anabolic steroids in an athlete. J. Clin. Pathol. 41:441–443, 1988.

    PubMed  CAS  Google Scholar 

  92. Su, T., Pagliaro M., Schmidt, P. J., Pickar, D., Wolkowitz, O., Rubinow D. R. Neuropsychiatric effects of anabolic steroids in male normal volunteers. JAMA. 269:2760–2764, 1993.

    PubMed  CAS  Google Scholar 

  93. Pope, H. G. and Katz, D. L. Psychiatric and medical effects of anabolic-androgenic steroid use. Arch. Gen. Psychiatry. 51:375–382, 1994.

    PubMed  CAS  Google Scholar 

  94. Corrigan, B. Anabolic steroids and the mind. Med. J. Aust. 165:222–226, 1996.

    PubMed  CAS  Google Scholar 

  95. British Medical Association. Drugs in Sport. The Pressure to Perform. BMA, London, 2002.

    Google Scholar 

  96. Perry, H. M., Wright, D., Littlepage, B. N. C. Dying to be big: a review of anabolic steroid use. Br J Sports Med. 26:259–261, 1992.

    PubMed  CAS  Google Scholar 

  97. Littlepage, B. N. C. and Perry, H. M. Misusing anabolic drugs: possibilities for future policies. Addiction. 88:1469–1471, 1993.

    PubMed  CAS  Google Scholar 

  98. McBride, A. J., Williamson, K., Petersen, T. Three cases of nalbuphine hydrochloride dependence associated with anabolic steroid use. Br. J. Sports Med. 30:69–70, 1996.

    PubMed  CAS  Google Scholar 

  99. Elkin, S. L., Brady, S., Williams, I. P. Bodybuilders find it easy to obtain insulin to help them in training. Br. Med. J. 314:1280, 1997.

    CAS  Google Scholar 

  100. FitzSimmons, C. R. and Kidner, N. Caffeine toxicty in a bodybuilder. J. Acid Emerg. Med. 15:196–1970, 1998.

    CAS  Google Scholar 

  101. Perry, H. M. and Littlepage, B. N. C. Misusing anabolic drugs. Br. Med. J. 305:1241–1242, 1992.

    CAS  Google Scholar 

  102. Roth, R. H. and Giarman, N. J. Natural occurrence of gamma-hydroxybutyrate in mammalian brain. Biochem. Pharmacol. 19:1087–1093, 1970.

    CAS  Google Scholar 

  103. Galloway, G. P., Frederick, S. L., Staggers Jr, F. E., Gonzales, M., Stalcup, S. A., and Smith, D. E. Gamma-hydroxybutyrate: an emerging drug of abuse that causes physical dependence. Addiction. 92:89–96, 1997.

    PubMed  CAS  Google Scholar 

  104. Cohen, J. Drug Notes: 9 Poppers, Ketamine and GHB. London, Drugscope, 2002.

    Google Scholar 

  105. Ferrara, S. D., Zotti, S., Tedeshi, L., et al. Pharmacokinetics of gamma-hydroxybutyric acid in alcohol dependent patients after single and repeated oral doses. Br. J. Clin. Pharmacol. 34:231–235, 1992

    PubMed  CAS  Google Scholar 

  106. Luby, S., Jones, J., and Zalewski, A. GHB use in South Carolina. Am. J. Public Health. 82:128, 1992.

    PubMed  CAS  Google Scholar 

  107. Thomas, G., Bonner, S., and Gascoigne, A. Coma induced by abuse of gammahydroxybutyrate: a case report. Br. Med. J. 314, 35–36, 1997.

    CAS  Google Scholar 

  108. Dyer, J. E. ER admission cases discussed, in Getting the Scoop on GHB: The New Recreational Drug. Presented at the 49th Annual Meeting of the American Academy of Forensic Sciences, New York, 1997

    Google Scholar 

  109. Dyer, J. E., Kreutzer, R., Quatrrone, A., et al. Multistate outbreak of poisonings associated with the illicit use of gammahydroxybutyrate. JAMA. 265: 447–448, 1992.

    Google Scholar 

  110. McDonough, M. Glasper, A., Bearn, J. Managing gamma hydroxybutyrate or “liquid ecstasy” withdrawal-meta-analysis of published cases and reporting early experience in the UK. SSA Symposium Abstracts. Addiction Biology. 8:2,241–242, 2003.

    Google Scholar 

  111. Cohen, J. Drug Notes: 9 Poppers, Ketamine and GHB. London, Drugscope, 2002

    Google Scholar 

  112. Jansen, K. L. R. Non-medical use of ketamine. BMJ. 306: 601–602, 1993.

    PubMed  CAS  Google Scholar 

  113. Slogoff, S., Allen, G. W., Wessels, J. V. Clinical experience with subanaesthetic ketamine. Anesth Analg (Cleve). 53:354–358, 1974.

    CAS  Google Scholar 

  114. White, P. F., Way, W. L., Trevor, A. J. Ketamine: its pharmacology and therapeutic uses. Anaethesiology. 56:119–136, 1982.

    CAS  Google Scholar 

  115. Medicines Compendium. Ketalar. Datapharm Publications, London, 2002.

    Google Scholar 

  116. Moore, K. A., Kilbane, E. M., Jones, R., Kunsman, G. W., Levine, B., Smith, M. Tissue distribution of ketamine in a mixed drug fatality. J. Forensic Sci. 2:1183–1185, 1997.

    Google Scholar 

  117. Sigell, L. T., Kapp, F. T., Fusaro, G. A., Nelson E. D., Falck, R. S. Popping and snorting volatile nitrites: a current fad for getting high. Am J Psychiatry. 135:1216–1218, 1978.

    PubMed  CAS  Google Scholar 

  118. Schwartz, R. H. and Peary, P. Abuse of isobutyl nitrite inhalation (rush) by adolescents. Clin Pediatr. 25:308–310, 1986.

    CAS  Google Scholar 

  119. Stambach, T., Haire, K., Soni, N., and Booth, J. Saturday night blue—a case of near fatal poisoning from the abuse of amyl nitrite. J. Accid. Emerg. Med. 14:339–340, 1997.

    PubMed  CAS  Google Scholar 

  120. Virkkunen, M., and Linnoila, M. Brain serotonin, type II alcoholism and impulsive violence. J. Stud. Alcohol. 11(Suppl):163–169, 1993.

    CAS  Google Scholar 

  121. Magennis, P., Shepherd, J., Hutchison, I., Brown, A. Trends in facial injury. Br. Med. J. 316:325–326, 1998.

    CAS  Google Scholar 

  122. The All Party Group on Alcohol Abuse. Alcohol and Crime: Breaking the Link. Alcohol Concern, London, 1995.

    Google Scholar 

  123. Sumner, M., and Parker, H. Low in Alcohol. A Review of International Research into Alcohol’s Role in Crime Causation. The Portman Group, London, 1995.

    Google Scholar 

  124. Moore, M. R. and Moore, S. R. The potential for the use of personal computers in clinical forensic medicine. J. Clin. Forensic Med. 1:139–143, 1994.

    PubMed  CAS  Google Scholar 

  125. Robertson, G. The Role of Police Surgeons. The Royal Commission on Criminal Justice. Research Study No 6. Her Majesty’s Stationery Office, London, 1992.

    Google Scholar 

  126. Payne-James, J. J., Keys, D. W., Wall, I., Jerreat, P. G., Dean, P. J. Alcohol misuse in clinical forensic medicine. J. Clin. Forensic Med. 4:17–19, 1997.

    PubMed  CAS  Google Scholar 

  127. Best, D. Kefas, A. The role of alcohol in police-related deaths. Analysis of deaths in custody (Category 3) between 2000 and 2001. Police Complaints Authority, London, 2004.

    Google Scholar 

  128. Stockwell, T. and Stirling, L. Estimating alcohol content of drinks: common errors in applying the unit system. Br. Med. J. 298:571–572, 1989.

    CAS  Google Scholar 

  129. EEC Directive 766. 1976.

    Google Scholar 

  130. Ferner, R. E. Forensic Pharmacology. Medicines, Mayhem, and Malpractice. Oxford University Press, Oxford, 1996.

    Google Scholar 

  131. Baselt, R. C. Disposition of alcohol in man. In: Garriott, J, C., ed. Medicolegal Aspects of Alcohol, 3rd Ed. Lawyers and Judges Publishing Company, Tucson, AZ, 1996.

    Google Scholar 

  132. Stark, M. M. and Norfolk, G. A. Substance misuse. In: McLay, W. D. S. ed., Clinical Forensic Medicine. Greenwich Medical Media, London, 1996, pp. 173–179.

    Google Scholar 

  133. Holford, N. H. G. Clinical pharmacokinetics of ethanol. Clin. Pharmacokinet. 13:273–292, 1987.

    PubMed  CAS  Google Scholar 

  134. Wilkinson, P. K., Sedman, A. J., Sakmar, E., Earhart, R. H., Kay, D. R., Wagner, J. G. Pharmacokinetics of ethanol after oral administration in the fasting state. J. Pharmacokinet. Biopharm. 5:207–224, 1977.

    PubMed  CAS  Google Scholar 

  135. Jones, A. W. Biochemistry and physiology of alcohol: applications to forensic science and toxicology. In: Garriott, J. C., ed. Medicolegal Aspects of Alcohol, 3rd Ed. Lawyers and Judges, Tucson, AZ, 1996.

    Google Scholar 

  136. Drew, G. C., Colquhoun, W. P., Long, H. A. Effect of Small Doses of Alcohol on a Skill Resembling Driving. Medical Research Council Memorandum No. 38. Her Majesty’s Stationery Office, London, 1959.

    Google Scholar 

  137. Jones, A. W. and Jonsson, K. A. Between-subject and within-subject variations in the pharmacokinetics of ethanol. Br. J. Clin. Pharmacol. 37:427–431, 1994.

    PubMed  CAS  Google Scholar 

  138. Schultz, J., Weiner, H., Westcott, J. Retardation of ethanol absorption by food in the stomach. J. Stud. Alcohol. 41:861–870, 1980.

    Google Scholar 

  139. Jones, A. W., and Jonsson, K. A. Food-induced lowering of blood-ethanol profiles and increased rate of elimination immediately after a meal. J. Forensic Sci. 39:1084–1093, 1994.

    PubMed  CAS  Google Scholar 

  140. Sedman, A. J., Wilkinson, P. K., Sakmar, E., Weidler, D. J., Wagner, J. G. Food effects on absorption and elimination of alcohol. J. Stud. Alcohol. 37:1197–1214, 1976.

    PubMed  CAS  Google Scholar 

  141. Walls, H. and Brownlie, A. R. Drink, Drugs and Driving, 2nd Ed. Sweet and Maxwell, London, 1985.

    Google Scholar 

  142. Jones, A. W. and Sternebring, B. Kinetics of ethanol and methanol in alcoholics during detoxification. Alcohol Alcoholism. 27:641–647, 1992.

    CAS  Google Scholar 

  143. Manno, J. E. and Manno, B. R. Experimental basis of alcohol-induced psychomotor performance impairment. In: Garriott, J.C., ed., Medicolegal Aspects of Alcohol, 3rd Ed. Lawyers and Judges, Tucson, AZ, 1996.

    Google Scholar 

  144. Urso, T., Gavaler, J. S., Van Thiel, D. H. Blood ethanol levels in sober alcohol users seen in an emergency room. Life Sci. 28:1053–1056, 1981.

    PubMed  CAS  Google Scholar 

  145. Sullivan, J. B., Hauptman, M., Bronstein, A. C. Lack of observable intoxication in humans with high plasma alcohol concentrations. J. Forensic Sci. 32:1660–1665, 1987.

    PubMed  CAS  Google Scholar 

  146. Garriott, J. C. Pharmacology and toxicology of ethyl alcohol. In: Garriott, J.C., ed. Medicolegal Aspects of Alcohol, 3rd Ed. Lawyers and Judges, Tucson, AZ, 1996.

    Google Scholar 

  147. Money, K., and Myles, W. Heavy water nystagmus and effects of alcohol. Nature. 247:404–405, 1974.

    PubMed  CAS  Google Scholar 

  148. Behrens, M. M. Nystagmus. J. Ophthalmol Clin. 18:57–82, 1978.

    CAS  Google Scholar 

  149. Aschan, G. Different types of alcohol nystagmus. Acta Otolaryngol. 140(Suppl):69–78, 1958.

    CAS  Google Scholar 

  150. Aschan, G., Bergstedt, M., Goldberg, L., Laurell, L. Positional nystagmus in man during and after alcohol intoxication. Q. J. Stud. Alcohol. 17:381–405, 1956.

    PubMed  CAS  Google Scholar 

  151. Goding, G. S. and Dobie, R. A. Gaze nystagmus and blood alcohol. Laryngoscope. 96:713–717, 1986.

    PubMed  CAS  Google Scholar 

  152. Belton, H. Lateral nystagmus: a specific diagnostic sign of ethyl alcohol intoxication. N. Z. Med. J. 100:534–535, 1987.

    PubMed  CAS  Google Scholar 

  153. Eakins, W. A. Clinical signs and the level of blood alcohol. Police Surg. 11:8–15, 1977.

    Google Scholar 

  154. Willoughby, E. W. Nystagmus and alcohol intoxication. N. Z. Med. J. 100:640, 1987.

    PubMed  CAS  Google Scholar 

  155. Moczula, B. Alcohol and the law: the legal framework of scientific evidence and expert testimony. In: Garriott, J. C., ed. Medicolegal Aspects of Alcohol, 3rd Ed. Lawyers and Judges, Tucson, AZ, 1996.

    Google Scholar 

  156. British Medical Association. The Recognition of Intoxication. Report of a Special Committee of the British Medical Association. BMA, London, 1954.

    Google Scholar 

  157. Tennant, F. The rapid eye test to detect drug abuse. Postgrad. Med. 84:108–114, 1988.

    PubMed  CAS  Google Scholar 

  158. Fleming, P. and Stewart, D. Drugs and Driving: Training Implications for Police Officers and Police Surgeons. Home Office Police Policy Directorate, London, 1998.

    Google Scholar 

  159. Simpson-Crawford, T. and Slater, S. W. Eye signs in suspected drinking drivers: clinical examination and relation to blood alcohol. N. Z. Med. J. 74:92–96, 1971.

    PubMed  CAS  Google Scholar 

  160. Johnson, K., Pisoni, D. B., Bernacki, R. H. Do voice recordings reveal whether a person is intoxicated? A case study. Phonetica. 47:215–237, 1990.

    PubMed  CAS  Google Scholar 

  161. Martin, C. S. Measuring acute alcohol impairment. In: Karch, S. B., ed., Drug Abuse Handbook. CRC Press, Boca Raton, FL, 1998, pp. 309–326.

    Google Scholar 

  162. Potter, J. F., Watson, R. D. S., Skan, W., Beevers, D. G. The pressor and metabolic effects of alcohol in normotensive subjects. Hypertension. 8:625–631, 1986.

    PubMed  CAS  Google Scholar 

  163. Kelbaek, H., Gjorup, T., Brynjolf, I., Christensen, N. J., Godtfredsen, J. Acute effects of alcohol on left ventricular function in healthy subjects at rest and during upright exercise. Am. J. Cardiol. 55:164–167, 1985.

    PubMed  CAS  Google Scholar 

  164. Kaye, S. and Haag, H. B. Terminal blood alcohol concentrations in 94 fatal cases of alcoholism. JAMA. 165:451–452, 1957.

    CAS  Google Scholar 

  165. Johnson, R. A., Noll, E. C., MacMillan Rodney, W. Survival after a serum ethanol level of 1.5 per cent. Lancet. 2:1394, 1982.

    PubMed  CAS  Google Scholar 

  166. Rix, K. J. B. “Alcohol intoxication” or “drunkenness”: is there a difference? Med. Sci. Law. 29:100–106, 1989.

    PubMed  CAS  Google Scholar 

  167. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th Ed. American Psychiatric Association, Washington, D.C., 1994.

    Google Scholar 

  168. Norfolk, G. A. Deaths in police custody during 1994: a retrospective analysis. J. Clin. Forensic Med. 5:49–54, 1998.

    PubMed  CAS  Google Scholar 

  169. Royal College of Psychiatrists. Alcohol: Our Favourite Drug. Royal College of Psychiatrists, London, 1986.

    Google Scholar 

  170. Deehan, A., Stark, M. M., Marshall, E. J., Hanrahan, B., Strang, J. Drunken detainees in police custody: is brief intervention by the forensic medical examiner feasible? Crimin. Behav. Mental Health. 8:214–221, 1998.

    Google Scholar 

  171. Reilly, D., Van Beurden, E., Mitchell, E., Dight, R., Scott, C., Beard, J. Alcohol education in licensed premises using brief intervention strategies. Addiction. 93:385–398, 1998.

    PubMed  CAS  Google Scholar 

  172. Midanik, L. The validity of self-reported alcohol consumption and alcohol problems: a literature review. Br. J. Addic. 77:357–382, 1982.

    CAS  Google Scholar 

  173. Babor, T. F., Ramon de la Fuente, J., Saunders, J., Grant, M. DIT, The Alcohol Use Disorders Identification Test: Guidelines for use in Primary Health Care. World Health Organization, Geneva, 1992.

    Google Scholar 

  174. Pokorny, A. D., Miller, B. A., Kaplan, H. B. The brief MAST: a shortened version of the Michigan alcoholism screening test. Am. J. Psychiatry. 129:342–345, 1972.

    PubMed  CAS  Google Scholar 

  175. Hedlund, J. L., and Vieweg, B. W. The Michigan Alcoholism Screening Test (MAST): a comprehensive review. J. Operational Psychiatry. 15:55–65, 1984.

    Google Scholar 

  176. Mayfield, D., McLeod, G., Hall, P. The CAGE questionnaire: validation of a new alcoholism screening instrument. Am. J. Psychiatry. 131:1121–1123, 1974.

    PubMed  CAS  Google Scholar 

  177. Ewing, J. A. Detecting alcoholism. The CAGE questionnaire. JAMA. 252:1905–1907, 1984.

    PubMed  CAS  Google Scholar 

  178. Romach, M. K., and Sellers, E. M. Management of the alcohol withdrawal syndrome. Annu. Rev. Med. 42:323–340, 1991.

    PubMed  CAS  Google Scholar 

  179. Naik, P., and Lawton, J. (1993) Pharmacological management of alcohol withdrawal. Br. J. Hosp. Med. 50:265–269, 1991.

    PubMed  CAS  Google Scholar 

  180. Mayo-Smith, M. F. for the American Society of Addiction Medicine Working Group on Pharmacological Management of Alcohol Withdrawal. Pharmacological management of alcohol withdrawal. A meta-analysis and evidence-based practice guideline. JAMA. 278:144–151, 1997.

    PubMed  CAS  Google Scholar 

  181. Naik, P. and Lawton, J. Assessment and management of individuals under the influence of alcohol in police custody. J. Clin. Forensic Med. 3:37–44, 1996.

    PubMed  CAS  Google Scholar 

  182. Linnoila, M. I. Benzodiazepines and alcohol. J. Psychiatr Res. 24(Suppl 2):121–127, 1990.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and Permissions

Copyright information

© 2005 Humana Press Inc., Totowa, NJ

About this chapter

Cite this chapter

Stark, M.M., Norfolk, G. (2005). Substance Misuse. In: Stark, M.M. (eds) Clinical Forensic Medicine. Forensic Science and Medicine. Humana Press. https://doi.org/10.1385/1-59259-913-3:285

Download citation

  • DOI: https://doi.org/10.1385/1-59259-913-3:285

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-368-8

  • Online ISBN: 978-1-59259-913-4

  • eBook Packages: MedicineMedicine (R0)